Nationwide Implementation of Disease Eradication Programme : Bharati Pravin Pawar

New Delhi : The programme to eliminate various diseases namely Malaria, Lymphatic Filariasis, Kala-Azar, Tuberculosis, Leprosy have been implemented by Government of India. The National Centre for Vector Borne Diseases Control (NCVBDC) administers an umbrella programme, namely, National Vector Borne Diseases Control Programme (NVBDCP) for prevention and control of vector borne diseases. Under NVBDCP, three diseases namely Malaria, Filaria & Kala-Azar are under elimination programme. These diseases are targeted for elimination, and not for eradication. Eradication of the disease is permanent reduction to zero of the worldwide incidences of infection caused by specific agent as a result of deliberate efforts; and when intervention measures are no longer needed.

The aims, objectives and targets are as follows:

      1. Malaria is targeted for elimination by 2030
      2. Lymphatic Filariasis is targeted for elimination by 2030
      3. Kala Azar is targeted for elimination by 2023

For Leprosy, the government is implementing the National Leprosy Eradication Programme (NLEP) with the goal of making India leprosy free. NLEP is a centrally sponsored scheme under the umbrella of National Health Mission (NHM). NLEP is aimed to bring down Prevalence Rate of leprosy to less than 1/10,000 population at district level; Grade II Disability rate per million population to Zero at district level; Grade II Disability to Zero among new cases and child leprosy cases to zero level.  It also aims at generating awareness about leprosy disease.

For Tuberculosis, the Government is implementing National TB Elimination Programme (NTEP) with the goal of ending TB by 2025, five years ahead of the global targets of Sustainable Development Goals (SDGs) of 2030.

Detailed State/UT-wise budget for vector borne diseases, Leprosy and TB is given at Annexure.

  1. The following steps are taken by the Government to achieve the targets:


  • Early diagnosis and radical treatment: Use of Rapid Diagnostic Test Kits, ASHA incentives for diagnosis & ensuring complete treatment
  • Case-based surveillance and rapid response
  • Integrated vector management (IVM)
  • Indoor residual spray (IRS)- 2 rounds of IRS for vector control in areas with Annual Parasite Incidence >2.
  • Long-lasting insecticidal nets (LLINs) / Insecticide treated bed nets (ITNs): LLINs are being used in the programme to cover sub centres with Annual Parasite Incidence >1.
  • Larval source management (LSM)
  • Epidemic preparedness and early response
  • Behaviour Change Communication and community mobilization

Lymphatic Filariasis:

·  Mass Drug administration (MDA) for disease transmission control. To accelerate disease elimination, an Accelerated Plan for Elimination of Lymphatic filariasis (APELF) 2018, triple Drug Therapy (Ivermectin + Diethylcarbamazine (DEC) + Albendazole) has been implemented in 30 districts and is being further scaled up.

·   Morbidity Management & Disability Prevention (MMDP) targets 100% coverage for hydrocele surgery and home-based morbidity management services for lymphoedema cases.

· The achievement of<1% Microfilaria rate is validated by Transmission Assessment Survey (TAS).


  • Single Dose Liposomal Amphotericin B (LAMB) for treatment
  • Use of synthetic pyrethroid in place of DDT for IRS
  • Introduction of hand compression pumps in place of stirrup pumps for convenience and quality of IRS
  • Revised incentives to PKDL patients from Rs. 2,000/- to 4,000/- and to ASHA from Rs.300/- to 500/- in 2018
  • Pucca houses in KA affected villages have been constructed under PMAY-G – Total 25,955 houses in 2017-18 (1371 houses in Bihar & 24584 in Jharkhand)

National Leprosy Eradication Programme (NLEP):

  • A well laid out Operational strategy for Active Case Detection and Regular Surveillance has been put in place, both in rural and urban areas, through ASHAs and Frontline Workers in order to ensure detection of leprosy cases on regular basis and at an early stage in order to prevent grade II disabilities
  •  Leprosy screening has been integrated with Rashtriya Bal Swasthya Karyakram (RBSK) and Rashtriya Kishore Swasthya Karyakram (RKSK) for screening of children (0-18 years)
  •  Leprosy screening has been integrated with the activities of Comprehensive Primary Health Care under Ayushman Bharat – Health and Wellness Centre (AB-HWC) for screening of people above 30 years of age
  • Contact tracing is done and Post Exposure Prophylaxis (PEP) is administered to the eligible contacts of Index case (Person diagnosed with leprosy) in order to interrupt the chain of transmission at the community level
  • Various services are provided under the programme for Disability Prevention and Medical Rehabilitation (DPMR) i.e., reaction management, provision of Microcellular Rubber (MCR) footwear, Aids & Appliances, self-care kits etc.
  • Reconstructive Surgeries (RCS) are conducted at District Hospitals/Medical Colleges/ Central Leprosy Institutes, and welfare allowance @ Rs 8000 is paid to each patient undergoing RCS

National TB Elimination programme (NTEP):

  • Early diagnosis of all the TB patients, prompt treatment with quality assured drugs and treatment regimens along with suitable patient support systems to promote adherence
  • Engaging with the patients seeking care in the private sector
  • Prevention strategies including active case finding and contact tracing in high risk / vulnerable population
  • Airborne infection control.
  • Multi-sectoral response for addressing social determinants.




Financial assistance provided under integrated budget for VBDs, NLEP and NTEP for current year

Rs. In Lakhs
Andhra Pradesh       2182.36     160 5587
Arunachal Pradesh       6.78     95 1783
Assam       991.92     120 4828
Bihar       246.35     263 4118
Chhattisgarh       215.32     153 3832
Goa       4.68     5 322
Gujarat       1691.42     132 5755
Haryana       80.27     47 4454
Himachal Pradesh       1.67     26 1662
Jharkhand       327.82     190 4257
Karnataka       788.02     88 6992
Kerala       210.35     25 4163
Madhya Pradesh       33.03     198 7767
Maharashtra       75.82     430 10492
Manipur       1.00     20 2359
Meghalaya       152.00     35 1128
Mizoram       14.64     25 1414
Nagaland       0.56     75 1909
Odisha       154.17     219 5237
Punjab       123.26     66 4134
Rajasthan       113.14     62 4002
Sikkim       1.00     35 941
Tamil Nadu       48.06     165 6497
Telangana       21.97     132 5215
Tripura       655.86     22 1135
Uttar Pradesh       1879.45     420 13517
Uttarakhand       8.51     16 2227
West Bengal       83.33     195 7940
Delhi       0.00     85 1796
Puducherry       0.00     5 417
Jammu & Kashmir       0.00     28 2300
Andaman & Nicobar Islands       1.58     9 206
Chandigarh       7.85     9 418
Dadra & Nagar Haveli and Daman & Diu       52.45     10 323
Ladakh       0.00     2 390
Lakshadweep       0.00     9 62
Total       10174.64     3576 129579

*Upto 31st October, 2021

The Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar stated this in a written reply in the Rajya Sabha today.

Comments are closed.